PTJ
EVFM

Paul Tudor Jones’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Paul Tudor Jones’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,239
Closed -$45K – 1947
2020
Q4 		$45K Buy
+1,239
New +$44.8K ﹤0.01% 1289
2020
Q3 		– Sell
-17,184
Closed -$729K – 1621
2020
Q2 		$729K Buy
+17,184
New +$1.16M 0.04% 591

Other funds holding EVFM

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
GLA
Great Lakes Advisors Chicago, Illinois $13.1B AUM 34.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paul Tudor Jones's EVFM Position: Q1 2021 in Review

Paul Tudor Jones sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q1 2021, closing a stake of 1,239 shares — an estimated $45K sold.

Paul Tudor Jones first reported a position in EVFM in Q2 2020 and held it in 2 quarters. The position peaked at $729K in Q2 2020. 103 funds tracked by Wall St. Rank hold EVFM as of Q1 2021.

  • Paul Tudor Jones reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Paul Tudor Jones sold 1,239 Evofem Biosciences, Inc. Common Stock shares in Q1 2021, an estimated $45K.
  • Paul Tudor Jones first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Paul Tudor Jones's Evofem Biosciences, Inc. Common Stock position peaked at $729K in Q2 2020.
  • 103 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q1 2021.

Based on Tudor Investment Corp's 13F filing for Q1 2021, filed 17 May 2021.